Cannabielsoin for ​​Pharmacological

Cannabielsoin(CBE)  (CAS 52025-76-0) is a phytocannabinoid derivative with potential analgesic and neuroprotective applications. Its structural complexity and lipophilicity present challenges in drug development but also offer opportunities for targeted therapeutic formulations.